Trial intelligence / Profile preview

Monthly versus daily vitamin D3 dosing in adults with vitamin D deficiency

2016-003755-29Phase 4Completed

Sponsor
SMB Laboratoires
Start
Oct 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of AIDWELL-D3 and cholecalciferol in Vitamin D deficiency (VDD) (2 arms), sponsored by SMB Laboratoires. Primary endpoint: Primary endpoint: 25(OH)D3 serum concentration at day 75. Started Oct 2016; status: completed.

02

Drugs

AIDWELL-D3cholecalciferol
03

Conditions

Vitamin D deficiency (VDD)

Beyond the preview

Go deeper on 2016-003755-29.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2016-003755-29.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call